Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Clinical trial NCT05891093 · RECRUITING
Trial details
- NCT number
- NCT05891093
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2028-05-31
- Enrollment
- 766
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.